Skip to content
DraconiticResearch
Search Sources API
197,688 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Risk prediction for 12-month post-prostatectomy urinary incontinence to support survivorship care: development and same-center temporal validation of a perioperative model

  1. 1Department of Urology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
  2. 2Department of Urology, Guiyang First People’s Hospital

Abstract

Background: Persistent post-prostatectomy urinary incontinence (PPI) is a survivorship problem after radical prostatectomy with continuing implications for daily function, rehabilitation, follow-up, and supportive care. Risk stratification could help target these services, but uncommon events constrain model complexity and require evaluation beyond discrimination.

Objective: To develop a perioperative model for PPI 12 months after catheter removal using LASSO-penalized logistic regression, compare it with a constrained gradient boosting machine (GBM), and examine temporal performance in a later same-center cohort.

Methods: The development cohort comprised 726 patients with 51 PPI events (7.0%) and 19 candidate predictors. LASSO tuning used the one-standard-error rule within resampling, and the strategies were compared by nested repeated stratified five-fold cross-validation. The selected LASSO model was refitted to the full development cohort and applied without coefficient updating or recalibration to 465 later patients with 38 events (8.2%). Evaluation included ROC-AUC, average precision, Brier score, calibration-in-the-large (CITL), calibration slope, threshold-dependent measures, and decision-curve analysis.

Results: Eight original predictors were retained: age, preoperative International Prostate Symptom Score, ln(1 + prostate-specific antigen), operative time, postoperative hospital stay, smoking history, hypertension, and neurovascular bundle preservation. Nested internal validation yielded a ROC-AUC of 0.913 (95% CI 0.871–0.946), average precision of 0.542 (0.404–0.675), and Brier score of 0.046 (0.035–0.058) for LASSO, versus 0.896, 0.488, and 0.048 for constrained GBM. In the temporal cohort, ROC-AUC was 0.836 (0.763–0.900), average precision 0.409 (0.277–0.564), and Brier score 0.062 (0.045–0.081). CITL was 0.445 (0.012–0.808) and the calibration slope 0.850 (0.621–1.174), indicating average underprediction. At the development-derived threshold of 0.128, sensitivity was 0.500 and specificity 0.913. Decision-curve analysis indicated potential net benefit across thresholds of 2–30%.

Conclusion: The LASSO model retained useful temporal discrimination but underestimated absolute risk, and the development-derived cutoff did not transport well. It is therefore better suited to continuous risk estimation for survivorship follow-up and rehabilitation planning than to a fixed binary triage rule. Independent geographic validation, local calibration assessment, and prospective evaluation of clinical impact are required before routine use.

Related

  1. Development and validation of machine learning models for preoperative prediction of perioperative outcomes in patients with thymic epithelial tumors
    Yehong Li, Jianhao Qiu, Yue Zhao +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textNeurologyCrossref
  2. Perioperative tranexamic acid and postoperative haematuria after transvesical prostatectomy: a prospective observational cohort study
    Branka Terzić, Bogomir Milojević, Marko Živković +7
    BMC UrologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. Supporting implementation of the national standards for cancer survivorship care: development of the cancer survivorship maturity model (CSMM)
    Heidi Dowst, Maryem Shirzadi, Martha Mims +3
    Journal of Cancer SurvivorshipPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  4. Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration.
    Hao Wang, Yifei Zhang, Zhen Li +5
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC
  5. The ''Hamburg Life After Cancer Program'': Development, Implementation and Evaluation of a Structured Survivorship Program - Study Protocol of a Hybrid Effectiveness-Implementation Study
    H. Führes, J. von Grundherr, F. Wolters +10
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
BibTeX
@article{tang2026risk,
  title = {{Risk prediction for 12-month post-prostatectomy urinary incontinence to support survivorship care: development and same-center temporal validation of a perioperative model}},
  author = {Lang Tang and Ming Hao and Mengru Luo and Shizhu Li},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = oct,
  doi = {10.3389/fpubh.2026.1968281},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1968281/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Risk prediction for 12-month post-prostatectomy urinary incontinence to support survivorship care: development and same-center temporal validation of a perioperative model
AU  - Lang Tang
AU  - Ming Hao
AU  - Mengru Luo
AU  - Shizhu Li
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1968281
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1968281/full
AB  - Background: Persistent post-prostatectomy urinary incontinence (PPI) is a survivorship problem after radical prostatectomy with continuing implications for daily function, rehabilitation, follow-up, and supportive care. Risk stratification could help target these services, but uncommon events constrain model complexity and require evaluation beyond discrimination.  Objective: To develop a perioperative model for PPI 12 months after catheter removal using LASSO-penalized logistic regression, compare it with a constrained gradient boosting machine (GBM), and examine temporal performance in a later same-center cohort.  Methods: The development cohort comprised 726 patients with 51 PPI events (7.0%) and 19 candidate predictors. LASSO tuning used the one-standard-error rule within resampling, and the strategies were compared by nested repeated stratified five-fold cross-validation. The selected LASSO model was refitted to the full development cohort and applied without coefficient updating or recalibration to 465 later patients with 38 events (8.2%). Evaluation included ROC-AUC, average precision, Brier score, calibration-in-the-large (CITL), calibration slope, threshold-dependent measures, and decision-curve analysis.  Results: Eight original predictors were retained: age, preoperative International Prostate Symptom Score, ln(1 + prostate-specific antigen), operative time, postoperative hospital stay, smoking history, hypertension, and neurovascular bundle preservation. Nested internal validation yielded a ROC-AUC of 0.913 (95% CI 0.871–0.946), average precision of 0.542 (0.404–0.675), and Brier score of 0.046 (0.035–0.058) for LASSO, versus 0.896, 0.488, and 0.048 for constrained GBM. In the temporal cohort, ROC-AUC was 0.836 (0.763–0.900), average precision 0.409 (0.277–0.564), and Brier score 0.062 (0.045–0.081). CITL was 0.445 (0.012–0.808) and the calibration slope 0.850 (0.621–1.174), indicating average underprediction. At the development-derived threshold of 0.128, sensitivity was 0.500 and specificity 0.913. Decision-curve analysis indicated potential net benefit across thresholds of 2–30%.  Conclusion: The LASSO model retained useful temporal discrimination but underestimated absolute risk, and the development-derived cutoff did not transport well. It is therefore better suited to continuous risk estimation for survivorship follow-up and rehabilitation planning than to a fixed binary triage rule. Independent geographic validation, local calibration assessment, and prospective evaluation of clinical impact are required before routine use.
SN  - 2296-2565
ER  -